Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Study to Evaluate the Efficacy and Safety of Irochel (Unani Coded Formulation) for the Management of Transfusion-Induced Iron Overload in Thalassemia Patients in Comparison With Deferoxamine

NCT07782931 is registered in ClinicalTrials.gov with Hamdard University as lead sponsor.

NCT NCT07782931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07782931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Study to Evaluate the Efficacy and Safety of Irochel (Unani Coded Formulation) for the Management of Transfusion-Induced Iron Overload in Thalassemia Patients in Comparison With Deferoxamine
Lead sponsor
Hamdard University
Phase
Phase 3
Overall status
Completed
Start date
February 11, 2019
Completion date
December 30, 2022
Enrollment
132 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iron overload due to repeated red blood cell transfusions, thalassemia majors (beta-thalassemia major)